Regenxbio RGNX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $15.23M-55.8% | $34.47M-41.4% | $58.8M-26.1% | $79.56M-38.9% | $130.1M+126% | ||
| $135.26M-30.8% | $195.6M-9.2% | $215.4M-11.6% | $243.74M+76.9% | $137.77M-22.2% | ||
| $2.03M0.0% | $2.03M0.0% | $2.03M0.0% | $2.03M0.0% | $2.03M0.0% | ||
| $10.04M-61.9% | $26.38M+4.1% | $25.35M+25.5% | $20.2M+11.0% | $18.19M-11.1% | ||
| $11.54M-3.2% | $11.93M-7.8% | $12.94M+20.1% | $10.78M-2.9% | $11.09M+22.4% | ||
| $186.52M-33.7% | $281.28M-15.3% | $331.97M-11.2% | $373.75M+19.3% | $313.24M+12.7% | ||
| $101.87M-2.8% | $104.86M-2.5% | $107.52M-3.2% | $111.02M-3.0% | $114.5M-2.6% | ||
| $45.54M-3.4% | $47.16M-3.4% | $48.82M-3.3% | $50.47M-3.2% | $52.11M-3.0% | ||
| $5.51M+19.5% | $4.61M+8.1% | $4.27M+127% | $1.88M-37.1% | $2.99M-25.3% | ||
| $341.89M-24.5% | $453.03M-13.7% | $525.2M-9.6% | $581.03M+18.4% | $490.93M+5.4% | ||
| $21.21M-0.7% | $21.36M-4.1% | $22.27M+2.8% | $21.66M+13.7% | $19.04M-16.5% | ||
| $5.92M-43.4% | $10.45M-20.8% | $13.2M-5.6% | $13.98M+2.9% | $13.59M+11,716% | ||
| $7.87M-5.1% | $8.29M-8.7% | $9.07M+12.7% | $8.05M+1.3% | $7.94M+0.5% | ||
| $22.78M+20.2% | $18.94M-10.6% | $21.19M-11.0% | $23.8M-9.5% | $26.3M— | ||
| $71.11M-39.8% | $118.1M-5.2% | $124.57M+4.2% | $119.54M+12.0% | $106.73M+3.4% | ||
| $63.2M-3.1% | $65.22M-3.3% | $67.43M-3.2% | $69.65M-3.1% | $71.91M-3.0% | ||
| $622K-2.5% | $638K-1.5% | $648K-2.4% | $664K-2.4% | $680K-81.3% | ||
| $320.81M-8.4% | $350.3M-3.7% | $363.75M-1.0% | $367.35M+69.5% | $216.73M+5.0% | ||
| $5K0.0% | $5K0.0% | $5K0.0% | $5K0.0% | $5K0.0% | ||
| $1.24B+0.7% | $1.23B+0.7% | $1.22B+0.8% | $1.21B+0.9% | $1.2B+0.7% | ||
| -$1.22B-8.0% | -$1.13B-6.3% | -$1.06B-6.2% | -$996.94M-7.7% | -$926.07M+0.7% | ||
| -$870K-26.6% | -$687K-5.4% | -$652K+13.1% | -$750K+1.6% | -$762K-2.8% | ||
| $21.08M-79.5% | $102.73M-36.4% | $161.45M-24.4% | $213.68M-22.1% | $274.2M+5.6% | ||
| $341.89M-24.5% | $453.03M-13.7% | $525.2M-9.6% | $581.03M+18.4% | $490.93M+5.4% | ||
| $135.26M-30.8% | $195.6M-9.2% | $215.4M-11.6% | $243.74M+76.9% | $137.77M-22.2% | ||
| $14.44M+11.9% | $12.91M-33.7% | $19.47M0.0% | $19.48M+21.1% | $16.08M+16.8% | ||
| $5.51M+19.5% | $4.61M+8.1% | $4.27M+127% | $1.88M-37.1% | $2.99M-25.3% | ||
| $420K-81.8% | $2.31M-16.4% | $2.77M+74.6% | $1.58M+31.1% | $1.21M+155% | ||
| $45.54M-3.4% | $47.16M-3.4% | $48.82M-3.3% | $50.47M-3.2% | $52.11M-3.0% | ||
| $45.54M-3.4% | $47.16M-3.4% | $48.82M-3.3% | $50.47M-3.2% | $52.11M-3.0% | ||
| $5.51M+19.5% | $4.61M+8.1% | $4.27M+127% | $1.88M-37.1% | $2.99M-25.3% | ||
| $45.54M-3.4% | $47.16M-3.4% | $48.82M-3.3% | $50.47M-3.2% | $52.11M-3.0% | ||
| $5.51M+19.5% | $4.61M+8.1% | $4.27M+127% | $1.88M-37.1% | $2.99M-25.3% | ||
| $22.78M+20.2% | $18.94M-10.6% | $21.19M-11.0% | $23.8M-9.5% | $26.3M— | ||
| $21.89M-43.0% | $38.39M+0.2% | $38.32M+7.8% | $35.56M+50.7% | $23.6M-38.0% | ||
| $14.23M-64.1% | $39.61M-5.1% | $41.72M+3.5% | $40.3M— | —— | ||
| $22.78M+20.2% | $18.94M-10.6% | $21.19M-11.0% | $23.8M-9.5% | $26.3M— | ||
| $22.78M+20.2% | $18.94M-10.6% | $21.19M-11.0% | $23.8M-9.5% | $26.3M— | ||
| $71.07M-3.3% | $73.5M-3.9% | $76.51M-1.5% | $77.7M-2.7% | $79.85M-2.7% | ||
| $1.24B+0.7% | $1.23B+0.7% | $1.22B+0.8% | $1.21B+0.9% | $1.2B+0.7% | ||
| $5K0.0% | $5K0.0% | $5K0.0% | $5K0.0% | $5K0.0% | ||
| $11.54M-3.2% | $11.93M-7.8% | $12.94M+20.1% | $10.78M-2.9% | $11.09M+22.4% | ||
| $163.11M+10.6% | $147.41M-1.7% | $149.92M-2.5% | $153.69M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Regenxbio's total assets?
- Regenxbio (RGNX) holds $341.9M in total assets, down 30.4% year over year.
- How much debt does Regenxbio have?
- Regenxbio carries $71.1M in total debt against $21.1M of shareholders' equity, a debt-to-equity ratio of 3.37.
- How much cash does Regenxbio have?
- Regenxbio holds $15.2M in cash and equivalents.
- Can Regenxbio cover its short-term obligations?
- Its current ratio is 2.62 — current assets exceed current liabilities.
- Where does Regenxbio's balance sheet data come from?
- Every line is extracted from Regenxbio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
